Anisina | Interleukin Related interleukin-related.com

Product Name :
Anisina

Search keywords :
TR-100

drugId :
null

Target Vo:
Tropomyosin

Target Vo Short Name :
Tropomyosin

Moa_Name:
Tropomyosin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kazia Therapeutics

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SIRT2 Antibody
STAT1 Antibody (YA059)
RSK3 Antibody: RSK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK3. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Hamster.

Author: Interleukin Related

Related Posts